School of Medicine
Showing 3,031-3,040 of 5,029 Results
-
Maria Emilia Montez Rath
Assistant Professor (Research) of Medicine (Nephrology)
BioDr. Montez-Rath completed her PhD in Biostatistics from Boston University in 2008 focusing on methods for modeling interaction effects in studies involving populations with high levels of comorbidity, such as persons on dialysis. She is a senior biostatistician and director of the Biostatistics Core of the Division of Nephrology at Stanford University where she has been collaborating with faculty and fellows since 2010 to study a variety of research questions relevant to kidney disease. Her methodological interests are mainly data-driven and include the handling of missing data, survival analysis with an emphasis on models for time-varying covariates and competing risks, methods for analyzing epidemiologic studies, analysis of correlated data and comparative effectiveness studies, as well as data visualization.
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
BioDr. Montine is the Stanford Medicine Endowed Professor, Chair of Stanford Pathology Department, and member of the National Academy of Medicine. He received his education and medical training at Columbia University, McGill University, and Duke University, and was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology at the University of Washington where he was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and founding Director of the Pacific Udall Center, a NINDS-funded Center of Excellence for Parkinson’s Disease Research. Dr. Montine was Chair of the Department of Pathology at the University of Washington from 2010 to 2016 when he was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain. -
Joshua Mooney
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care MedicineCurrent Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Andrew Reese Moore
Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsI am co-mentored by Dr. Angela Rogers and Dr. Purvesh Khatri. My research focuses on leveraging machine learning on multi-omic data to evaluate the immune response in critical illness. It is striking that despite many years of studying infections, we still treat patients with severe infections the same as we did 30 years ago, with antimicrobials, fluids, and supportive care. The goal of my research is to bring the ideals of precision medicine to critical care. In particular, I am working to better quantify how the immune system responds to infections with the goal of being able to "read" the immune system and treat patients with the medications they need to successfully recover.
-
Lindsay Scott Moore, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery
BioDr. Moore is a board-certified, fellowship-trained physician-researcher in otology, neurotology, and lateral skull base surgery with Stanford Health Care Ear Institute. She is a clinical assistant professor in the Division of Otology-Neurotology, Department of Otolaryngology – Head and Neck Surgery at Stanford University School of Medicine.
Dr. Moore specializes in surgery for disorders of the middle ear, inner ear, ear canal, facial nerve, and skull base for adults and children. She provides expert care for hearing loss and deafness, including cochlear implants for hearing loss. Other areas of expertise include vestibular schwannomas and other tumors of the lateral skull base, cerebrospinal fluid leaks (when membranes around the brain and spinal cord have a hole or tear), and cholesteatoma (noncancerous inner ear cysts). She also specializes in tympanic membrane (eardrum) perforations, glomus (rare and usually benign) skull base tumors (paragangliomas), and ear and temporal bone cancers.
Dr. Moore brings her clinical, surgical, and research expertise together to apply laboratory research to real-life patient care. Her research interests include optical and fluorescence molecular imaging (advanced, noninvasive imaging techniques) and applications in intraoperative surgical navigation to guide safe and effective resection of tumors. She also researches molecular characterization, used to show molecular characteristics of tissues and cells, with applications in targeted drug development. She applies her research to conditions including vestibular schwannoma (a noncancerous tumor on nerves connecting the ears and brain), cholesteatoma, skull base neoplasms (cancerous or noncancerous tumors), and hearing loss.
Additionally, Dr. Moore has a special interest in translational human clinical trials, including trial design and regulatory process navigation. Using her clinical trial experience, she works to apply novel investigations and treatment advances in her field. Her clinical research interests include treating and managing vestibular schwannoma, cholesteatoma, and other neoplasms of the ear and lateral skull base.
Dr. Moore has published her work in many peer-reviewed journals, including Nature Communications, Clinical Cancer Research, Annals of Surgery, Journal of Nuclear Medicine, and JAMA Otolaryngology — Head & Neck Surgery. She has given lectures and served on discussion panels at numerous national conferences and meetings. Her presentations have covered her work using novel molecular imaging techniques for surgery of vestibular schwannoma and head and neck cancers, clinical trials exploring therapies for vestibular schwannoma, and clinical trial development and implementation in neurotology.
Dr. Moore is a member of the American Academy of Otolaryngology-Head and Neck Surgery, American Neurotology Society, International Society for Fluorescence Guided Surgery, and the World Molecular Imaging Society.
